Big Pharma lobbies hard to curb generics
News | 16 August 2012
MUMBAI: India's tag of 'pharmacy of the developing world' is at a serious threat. Not only has the US devised new treaties to challenge generic drugs being shipped from India, the EU has also upped the ante. Worse, Big Pharma is increasingly adopting ...
Click on the link to read the full article at Times of India
(This link will open in a new window)
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
